Healthcare
-
Nicole Eggert’s Cancer Bills and a Trial That Cut Financial Toxicity for Patients
Despite insurance, out-of-pocket costs and lost wages create fiscal survival challenges for patients, as seen in Nicole Eggert’s battle.
-
BioSapien Begins First-in-Human MediChip Trial for Rectal Cancer at Burjeel
Abu Dhabi startup BioSapien doses first patient in Phase I trial evaluating its biodegradable MediChip implant to deliver localized chemotherapy directly to…
-
Hospital Beds for Critically Ill Kids Vanish as Costs Rise
Nationwide closures of pediatric units convert beds to adult care, forcing families to travel hours for lifesaving treatment.
-
Four in 10 US Adults Carry Health Care Debt as Michigan Wipes Another $21 Million
Learn how insured patients can navigate hospital billing departments, leverage legal protections, and manage unexpected medical debt.
-
Stanford Digital Twins Point to a Drug Pair That May Delay Preterm Labor
Researchers use immune system simulations to find a drug pair that delays labor 15 times better than aspirin alone, offering hope for…
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
Phase 1 trial of OSK gene therapy in three glaucoma patients finds no serious side effects and preliminary visual field improvements at…
-
Why Medicare Documentation Rules Drive Denied Claims for Diabetic Shoes
Missing paperwork accounts for 85.5% of improper Medicare payments for diabetic shoes, highlighting strict compliance hurdles for patients and providers.
-
Understanding CIPI: Envita Medical Centers’ In-Tumor Injection Treatment
A neutral explainer detailing what Chemo Immuno Precision Injections are, how the procedure works at Envita Medical Centers, and its evidence status.
-
How Virginia Medicaid Can Bill an Estate $38,000 for Premiums Paid to a Health Plan
Understand the legal mechanisms behind state estate recovery programs, managed care capitation payments, and how families face unexpected property claims.
-
The Growing Financial and Regulatory Realities of Concierge Medicine Models
As concierge practices surge in popularity, patients and providers must navigate complex Medicare rules regarding membership fees and covered services.
-
How a Hidden Fat-Sensing Protein Could Unlock Immunotherapy for Deadly Colorectal Cancers
A new study reveals how tweaking a single molecular switch in immune cells could turn ‘untreatable’ tumors into immunotherapy responders—without headlines.
-
FDA Approves Zanvastro, the First Drug for the Rare Brain Disorder Alexander Disease
Madison, October 16 — The US Food and Drug Administration has approved Zanvastro, the first drug designed to directly treat Alexander disease,…
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
The landmark trial published in NEJM found Dexcom G7 users achieved 0.9% greater A1C reduction versus routine care, with five more hours…
-
Two FDA-Approved MASH Drugs Give Patients New Options, and UCLA Health Offers a Way to Choose
LOS ANGELES, October 14 — On this date, the U.S. Food and Drug Administration granted approval to two drugs, Resmetirom and semaglutide,…
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
WASHINGTON, July 7 — A 13-year gap between a mother’s breast cancer diagnosis and her daughter’s own diagnosis has laid bare persistent…
-
Manufacturing Site Issues Delay FDA Decision on Novo’s Once-Monthly Hemophilia A Drug Denecimig
Bagsværd, October 6 — Novo Nordisk confirmed on October 2 that the FDA review of its denecimig biologics license application remains delayed…
-
FDA Approved All Eight Rare Disease Decisions Due in September 2026, Six of Them Early
WASHINGTON, October 2 — The FDA’s October 2026 decision calendar is relatively light compared to previous months, with a limited number of…
-
Jimmy Carter’s Melanoma Treatment Changed Cancer Care, Doctors Say
Rome, October 1 — The mechanics here are straightforward: immunotherapy, a breakthrough in cancer treatment, has generated significant revenue for biotechnology companies,…
-
Blue Cross Blue Shield Association Ties Hospital AI Coding Tools to $942 Million in Added Costs
BERKELEY, September 27 — Artificial intelligence tools used in medical billing and claims processing pushed patient costs up by nearly $1 billion…
-
Immunotherapy Emerges as the Fourth Pillar of Cancer Care, Experts Say
ISLAMABAD, September 20 — Cancer immunotherapy, the approach that harnesses the body’s own immune system to fight tumours, has become the fourth…
-
AHA-Kaufman Hall Report Urges Broader Review of Hospital Mergers
CHICAGO, September 16 — Nearly 60% of hospital patient days in the United States are attributable to Medicare, Medicaid and Medicare Advantage…
-
PAHO Opens HIV Prevention Injection Access for Fourteen Nations
WASHINGTON, September 15 — The Pan American Health Organization announced a new pathway on Tuesday that will let 14 countries in Latin…
-
How Stereotypes Led to Decades of Missed Autism Diagnoses in Girls and Women
WASHINGTON D.C., August 2 — A significant recalibration in the understanding and diagnosis of autism spectrum disorder (ASD) in women is underway,…
-
Testicular Rupture: Causes and Surgical Treatment Explained
NEW YORK, July 21 — A rare but serious injury known as testicular rupture has drawn attention after Kuroda-Grauer underwent emergency surgery…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992